SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-08-037483
Filing Date
2008-06-06
Accepted
2008-06-06 17:50:29
Documents
1
Period of Report
2008-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd210142.html 4  
1 FORM 4 rrd210142.xml 4 3792
  Complete submission text file 0001181431-08-037483.txt   5927
Mailing Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006
Business Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006 4253730171
SCOLR Pharma, Inc. (Issuer) CIK: 0000934936 (see all company filings)

IRS No.: 911689591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences

Mailing Address C/O SCOLR PHARMA INC. 3625 132ND AVENUE S.E., SUITE 300 BELLEVUE WA 98006
Business Address (425) 373-0171
MITCHEL ALAN M (Reporting) CIK: 0001313578 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31982 | Film No.: 08886663